AI phone app to help teens and young adults with epilepsy take their medicine
Part of Brain & nervous system clinical trials.
This study tests a mobile app that uses artificial intelligence to help people with epilepsy remember to take their anti-seizure medication. It is for teens and young adults (ages 14-24) living in Florida who are from underserved communities.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with epilepsy
- You are between 14 and 24 years old
- You currently take medicine for seizures
- You live in Florida
- You can read, speak, and write in English
- You come from a group that is underrepresented in research or have low income (like being on public assistance)
- You own a smartphone or tablet with internet
- You can use a phone keyboard or touchscreen
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a smartphone app called EPIDAY that predicts when you might have an epileptic seizure. By using the app, you could get early warnings and better manage your daily life.
This study tests a program that helps teenagers with epilepsy learn skills to manage their condition day-to-day. It aims to see if the program is helpful and easy to use for teens and their families.
This trial tests a smartphone-based AI system to help manage epilepsy long-term in rural areas. It is for people who have had at least one convulsive seizure in the past year and can use a smartphone with a caregiver.
This study tests a mobile app that uses artificial intelligence to help people with diabetes manage their condition. If you have had diabetes for at least a year and use an Android phone, you may be able to join and get support for your daily diabetes care.
This trial tests a mobile app that delivers personalized cognitive behavioral therapy (a structured talk-therapy approach that helps change unhelpful thoughts and behaviors). It may help reduce symptoms of anxiety, depression, or bipolar disorder for people who fit the study’s timing and safety requirements.
This trial tests a mobile app that uses artificial intelligence to help women with early-stage breast cancer manage symptoms during their first chemotherapy. The app is in Arabic and is designed to make it easier to report how you're feeling and get support.
Hear when a new Epilepsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.